Serum CA 125, Carcinoembryonic Antigen, and CA 19-9 as Tumor Markers in Borderline Ovarian Tumors

This publication has 11 references indexed in Scilit:

• Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: Differential diagnosis between colonic and ovarian carcinomas as primary sites
  Human Pathology, 1998
• Clinical Value of CA125, CA19-9, CEA, CA72-4, and TPA in Borderline Ovarian Tumor
  Gynecologic Oncology, 1996
• Prognosis and management of borderline tumours of the ovary
  Current Opinion in Obstetrics and Gynecology, 1996
• Management of Epithelial Ovarian Tumors of Low Malignant Potential
  Gynecologic Oncology, 1994
• CA 125 in gynecological pathology — a review
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1993
• Cancer-Associated Antigen CA 195 in Patients with Mucino&ypsilon;s Ovarian Tumours: A Comparative Analysis with CEA, TATI and CA 125 in Serum Specimens and Cyst Fluids
  Tumor Biology, 1993
• The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: Relevance for differential diagnosis
  Gynecologic Oncology, 1992
• A Prospective Study of Tumor Markers CA 125 and CA 19.9 in Patients with Epithelial Ovarian Carcinomas
  Tumor Biology, 1992
• Cancer antigen 125, carcinoembryonic antigen, and carbohydrate determinant 19-9 in ovarian tumors
  Cancer, 1990
• Announcement
  American Journal of Obstetrics and Gynecology, 1987